Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hydatidiform moles are pregnancies characterized by abnormal development of both embryonic and extraembryonic tissues and are associated with the misexpression of imprinted genes. The vast majority of complete hydatidiform moles are diploid and androgenetic, whereas partial hydatidiform moles are triploid, with an extra set of chromosomes of paternal origin. Here, we present an unusual complete
mole
that showed strong expression of two imprinted, maternally transcribed genes, CDKN1C (encoding p57(KIP2)) and
PHLDA2
(
TSSC3
/
IPL
), both part of a large imprinted gene domain on chromosome 11. Using microsatellite genotyping and fluorescent in situ hybridization, we show that this paradoxical gene expression was due to retention of a maternal copy of chromosome 11 in addition to the two paternal copies normally present in complete moles. These findings demonstrate that, despite being predominantly androgenetic, some complete moles contain small amounts of DNA of maternal origin. Furthermore, these results provide an explanation for rare false negatives that can arise when p57(KIP2) is used as a diagnostic marker for complete moles.
...
PMID:Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. 1531 11
Pigmented nevi are a heterogeneous group of lesions that range from uniquely curable with laser treatment, to partially responsive, to unresponsive or dangerous. This article presents laser and
IPL
treatment strategies from a clinical perspective for
nevi
organized by their typical responsiveness. A rationale for surgical excision, laser, and/or medical therapy in individual patients is also presented. Despite significant recent progress, it is clear that much understanding are still lacking about optimal laser treatment for pigmented lesions.
...
PMID:Treatment of melanocytic nevi. 1622 23
Angioma serpiginosum, first described by Hutchinson in 1889, is a rare benign vascular
nevus
with dilatation and proliferation of the capillaries in the upper dermis. A 15-year-old boy presented with an angioma serpiginosum on the right side of the body following the lines of Blaschko. Both the clinical pattern and the appearance in a male are unusual. Treatment with
IPL
technology (intense pulsed light), which emits polychromatic light from a high-intensity flashlamp, proved to be an effective approach.
...
PMID:[Angioma serpiginosum following the lines of Blaschko--an effective treatment with the IPL technology]. 1689 67
A total of 297 samples of hydropic villi were classified according to DNA polymorphisms as androgenetic moles, dispermic triploids, or biparental diploids. A subset of 267 appropriate samples was included in the study. Most of the macroscopically diagnosed complete
mole
cases were genetically androgenetic in origin. The partial
mole
cases consisted of 30 androgenetic moles and 12 dispermic triploids. For the 59 cases macroscopically categorized as hydropic abortion, the genetic analysis revealed 38 androgenetic moles, seven dispermic triploids and 14 biparental diploids. These results showed that a new diagnostic method was required for the management of patients with hydropic villi. We identified the TSSC imprint gene of which expression was shown in normal and partial
mole
villi but was silenced in complete
mole
villi. Immunohistochemistry using the
TSSC3
antibody demonstrated its efficacy as the differential diagnostic method.
TSSC3
play an important role in the differentiation from trophoblast stem cells to progenitors and/or labyrinth trophoblast through the
TSSC3
/PI3K/Akt/Mash2 signaling pathway.
...
PMID:Establishment of a new diagnostic method for hydropic villi by using TSSC3 antibody. 2380 5